icrf44 Search Results


92
Novus Biologicals cd11b
Figure 2 Modulation of liver myeloid and lymphoid compartments by nelitolimod via pressure-enabled drug delivery was preserved in combination with Sys or SQ checkpoint inhibitor. Liver of tumor-bearing mice were harvested 10 days post- treatment. CD45+ cells were isolated from non-parenchymal cells. (A) MDSC cell population <t>(CD11b+Gr1+),</t> (B) monocytic MDSCs (M-MDSC; CD11b+Ly6C+/hiLy6G−/lo), (C) dendritic (CD11c+) cells, (D) B cells (B220+), (E) T cells (CD3+) and (F) M1- like macrophage (F/4/80+CD38+EGR2−) were quantified by flow cytometry. (G) i (a–h) Tumors were isolated from each group, OCT-mounted tissues were sectioned, fixed, and stained for CD3 (green), CD8 (red), CD11b (green), and Gr1 (red). (G) ii–iii Quantification of CD11b+Gr1+ MDSCs and CD3+CD8+T cells and from tumors of mice were performed across five fields/mouse and n=3 mice were used per group. Scale (20 µm). Animal data were presented as mean±SEM from and n was mentioned in the individual graph. One-way analysis of variance was performed to determine statistical differences among multiple groups. MDSC, myeloid-derived suppressor cells; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; OCT, Optimal temperature cutting compound; DAPI, 4′,6-Diamidino-2-phenylindole; SQ, subcutaneous; Sys, systemic; Veh, vehicle.
Cd11b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/icrf44/pm39038918-181-11-25?v=Novus+Biologicals
Average 92 stars, based on 1 article reviews
cd11b - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

92
Novus Biologicals icrf44
Figure 2 Modulation of liver myeloid and lymphoid compartments by nelitolimod via pressure-enabled drug delivery was preserved in combination with Sys or SQ checkpoint inhibitor. Liver of tumor-bearing mice were harvested 10 days post- treatment. CD45+ cells were isolated from non-parenchymal cells. (A) MDSC cell population <t>(CD11b+Gr1+),</t> (B) monocytic MDSCs (M-MDSC; CD11b+Ly6C+/hiLy6G−/lo), (C) dendritic (CD11c+) cells, (D) B cells (B220+), (E) T cells (CD3+) and (F) M1- like macrophage (F/4/80+CD38+EGR2−) were quantified by flow cytometry. (G) i (a–h) Tumors were isolated from each group, OCT-mounted tissues were sectioned, fixed, and stained for CD3 (green), CD8 (red), CD11b (green), and Gr1 (red). (G) ii–iii Quantification of CD11b+Gr1+ MDSCs and CD3+CD8+T cells and from tumors of mice were performed across five fields/mouse and n=3 mice were used per group. Scale (20 µm). Animal data were presented as mean±SEM from and n was mentioned in the individual graph. One-way analysis of variance was performed to determine statistical differences among multiple groups. MDSC, myeloid-derived suppressor cells; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; OCT, Optimal temperature cutting compound; DAPI, 4′,6-Diamidino-2-phenylindole; SQ, subcutaneous; Sys, systemic; Veh, vehicle.
Icrf44, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/icrf44/bio_rxiv__2024__09__08__611916-188-28-30?v=Novus+Biologicals
Average 92 stars, based on 1 article reviews
icrf44 - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

94
fluidigm cd11b mac 1
Antibodies for CyTOF
Cd11b Mac 1, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/icrf44/pmc10521424-58-2-7?v=fluidigm
Average 94 stars, based on 1 article reviews
cd11b mac 1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
fluidigm icrf44

Icrf44, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/icrf44/pmc07963480-39-13-5?v=fluidigm
Average 94 stars, based on 1 article reviews
icrf44 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Becton Dickinson mouse anti-human cd11b-v450 icrf44

Mouse Anti Human Cd11b V450 Icrf44, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/icrf44/pmc08837256-64-8-14?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
mouse anti-human cd11b-v450 icrf44 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

N/A
The CD11b Antibody (ICRF44) [DyLight 594] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
  Buy from Supplier

N/A
Isotype Note IgG1 kappa Host Species Note Mouse Reactivity Note Human Pig Baboon Chimpanzee
  Buy from Supplier

N/A
Isotype Note IgG1 kappa Host Species Note Mouse Reactivity Note Human Pig Baboon Chimpanzee
  Buy from Supplier

N/A
The CD11b Antibody (ICRF44) [PE/Atto594] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry.
  Buy from Supplier

N/A
The CD11b Antibody (ICRF44) [DyLight 550] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
  Buy from Supplier

N/A
The CD11b Antibody (ICRF44) [Janelia Fluor® 549] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
  Buy from Supplier

Image Search Results


Figure 2 Modulation of liver myeloid and lymphoid compartments by nelitolimod via pressure-enabled drug delivery was preserved in combination with Sys or SQ checkpoint inhibitor. Liver of tumor-bearing mice were harvested 10 days post- treatment. CD45+ cells were isolated from non-parenchymal cells. (A) MDSC cell population (CD11b+Gr1+), (B) monocytic MDSCs (M-MDSC; CD11b+Ly6C+/hiLy6G−/lo), (C) dendritic (CD11c+) cells, (D) B cells (B220+), (E) T cells (CD3+) and (F) M1- like macrophage (F/4/80+CD38+EGR2−) were quantified by flow cytometry. (G) i (a–h) Tumors were isolated from each group, OCT-mounted tissues were sectioned, fixed, and stained for CD3 (green), CD8 (red), CD11b (green), and Gr1 (red). (G) ii–iii Quantification of CD11b+Gr1+ MDSCs and CD3+CD8+T cells and from tumors of mice were performed across five fields/mouse and n=3 mice were used per group. Scale (20 µm). Animal data were presented as mean±SEM from and n was mentioned in the individual graph. One-way analysis of variance was performed to determine statistical differences among multiple groups. MDSC, myeloid-derived suppressor cells; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; OCT, Optimal temperature cutting compound; DAPI, 4′,6-Diamidino-2-phenylindole; SQ, subcutaneous; Sys, systemic; Veh, vehicle.

Journal: Journal for immunotherapy of cancer

Article Title: Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases.

doi: 10.1136/jitc-2024-008837

Figure Lengend Snippet: Figure 2 Modulation of liver myeloid and lymphoid compartments by nelitolimod via pressure-enabled drug delivery was preserved in combination with Sys or SQ checkpoint inhibitor. Liver of tumor-bearing mice were harvested 10 days post- treatment. CD45+ cells were isolated from non-parenchymal cells. (A) MDSC cell population (CD11b+Gr1+), (B) monocytic MDSCs (M-MDSC; CD11b+Ly6C+/hiLy6G−/lo), (C) dendritic (CD11c+) cells, (D) B cells (B220+), (E) T cells (CD3+) and (F) M1- like macrophage (F/4/80+CD38+EGR2−) were quantified by flow cytometry. (G) i (a–h) Tumors were isolated from each group, OCT-mounted tissues were sectioned, fixed, and stained for CD3 (green), CD8 (red), CD11b (green), and Gr1 (red). (G) ii–iii Quantification of CD11b+Gr1+ MDSCs and CD3+CD8+T cells and from tumors of mice were performed across five fields/mouse and n=3 mice were used per group. Scale (20 µm). Animal data were presented as mean±SEM from and n was mentioned in the individual graph. One-way analysis of variance was performed to determine statistical differences among multiple groups. MDSC, myeloid-derived suppressor cells; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; OCT, Optimal temperature cutting compound; DAPI, 4′,6-Diamidino-2-phenylindole; SQ, subcutaneous; Sys, systemic; Veh, vehicle.

Article Snippet: Primary antibodies and their corresponding clones used for immunofluorescence (IF) staining: CD11b; E6E1M (Cell Signaling, Massachusetts, USA), GR1; RB6- 8C5 (BioLegend, California, USA), CD3; SP7 (Novus Biologicals, USA) and CD8a; 53–6.7 μ (BioLegend, California, USA).

Techniques: Isolation, Flow Cytometry, Staining, Derivative Assay

Antibodies for CyTOF

Journal: Journal of Neuroinflammation

Article Title: Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis

doi: 10.1186/s12974-023-02900-z

Figure Lengend Snippet: Antibodies for CyTOF

Article Snippet: 209Bi , CD11b (Mac-1) , ICRF44 , Standard BioTools , 0.5 , Surface.

Techniques: Concentration Assay

Journal: eLife

Article Title: Seroconversion stages COVID19 into distinct pathophysiological states

doi: 10.7554/eLife.65508

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-Human CD11b , Fluidigm , Cat# 3209003B, RRID: AB_2687654 , Monoclonal-Clone: ICRF44 Dilution: 1/200.

Techniques: Staining, Biomarker Discovery, Software